Construction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzae

Clinical and Vaccine Immunology

Volumn 17, Issue 10, 2010, Pages 1567-1575

  Winter, Linda E ^a   Barenkamp, Stephen J ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ADHESIN; ANTIBODY; EPITOPE; HAEMOPHILUS INFLUENZAE VACCINE; HYBRID PROTEIN; PROTEIN HIA; PROTEIN HMW1; PROTEIN HMW2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; CELL STRAIN HEK293; CHINCHILLA; CONTROLLED STUDY; GENE EXPRESSION SYSTEM; GENETIC TRANSFECTION; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNOGENICITY; MOLECULAR CLONING; MUCOSAL IMMUNITY; NONHUMAN; PLASMID; PRIORITY JOURNAL; STRUCTURAL GENE; VIRUS PLAQUE; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ADHESINS, BACTERIAL; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; CELL LINE; EPITOPES, B-LYMPHOCYTE; GENE EXPRESSION; GENETIC VECTORS; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS VACCINES; HUMANS; INJECTIONS, INTRAPERITONEAL; PLAQUE ASSAY; PLASMIDS; RABBITS; RECOMBINANT FUSION PROTEINS; VACCINES, SYNTHETIC;

EID: 77957878974     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00115-10     Document Type: Article

References (69)

1. Akkoyunlu, M., H. Janson, M. Ruan, and A. Forsgren. 1996. Biological activity of serum antibodies to a nonacylated form of lipoprotein D of Haemophilus influenzae. Infect. Immun. 64:4586-4592.
2. Apicella, M. A. 2009. Bacterial otitis media, the chinchilla middle ear, and biofilms. J. Infect. Dis. 199:774-775.
3. Arevalo, M. T., Q. Xu, J. C. Paton, S. K. Hollingshead, M. E. Pichichero, D. E. Briles, N. Girgis, and M. Zeng. 2009. Mucosal vaccination with a multicomponent adenovirus-vectored vaccine protects against Streptococcus pneumoniae infection in the lung. FEMS Immunol. Med. Microbiol. 55:346-351.
4. Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69: 6718-6724.
5. Bakaletz, L. O., B.-J. Kennedy, L. A. Novotny, G. Duquesne, J. Cohen, and Y. Lobet. 1999. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect. Immun. 67:2746-2762.
6. Barenkamp, S. J. 1996. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas. Infect. Immun. 64:1246-1251.
7. Barenkamp, S. J., and F. F. Bodor. 1990. Development of serum bactericidal activity following nontypable Haemophilus influenzae acute otitis media. Pediatr. Infect. Dis. J. 9:333-339.
8. Barenkamp, S. J., and E. Leininger. 1992. Cloning, expression, and DNA sequence analysis of genes encoding nontypeable Haemophilus influenzae high-molecular-weight surface-exposed proteins related to filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 60:1302-1313.
9. Barenkamp, S. J., and J. W. St. Geme III. 1994. Genes encoding high-molecular- weight adhesion proteins of nontypeable Haemophilus influenzae are part of gene clusters. Infect. Immun. 62:3320-3328.
10. Barenkamp, S. J., and J. W. St. Geme III. 1996. Identification of surface-exposed B-cell epitopes on high molecular-weight adhesion proteins of nontypeable Haemophilus influenzae. Infect. Immun. 64:3032-3037.
11. Barenkamp, S. J., and J. W. St. Geme III. 1996. Identification of a second family of high-molecular-weight adhesion proteins expressed by non-typable Haemophilus influenzae. Mol. Microbiol. 19:1215-1223.
12. Barkai, G., E. Leibovitz, N. Givon-Lavi, and R. Dagan. 2009. Potential contribution by nontypable Haemophilus influenzae in protracted and recurrent acute otitis media. Pediatr. Infect. Dis. J. 28:466-471.
13. Barouch, D. H., and G. J. Nabel. 2005. Adenovirus vector-based vaccines for human immunodeficiency virus type 1. Hum. Gene Ther. 16:149-156.
14. Bergquist, C., E. L. Johansson, T. Lagergard, J. Holmgren, and A. Rudin. 1997. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect. Immun. 65:2676-2684.
15. Berman, S. 1995. Otitis media in children. N. Engl. J. Med. 332:1560-1565.
16. Berman, S. 1995. Otitis media in developing countries. Pediatrics 96:126-131.
17. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, M. J. McElrath, D. R. Casimiro, K. M. Gottesdiener, J. A. Chodakewitz, L. Corey, M. N. Robertson, and Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372:1881-1893.
18. Casey, J. R., and M. E. Pichichero. 2004. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr. Infect. Dis. J. 23:824-828.
19. Cripps, A. W., and J. M. Kyd. 2007. Comparison of mucosal and parenteral immunisation in two animal models of pneumococcal infection: otitis media and acute pneumonia. Vaccine 25:2471-2477.
20. Dagan, R., A. Hoberman, C. Johnson, E. L. Leibovitz, A. Arguedas, F. V. Rose, B. R. Wynne, and M. R. Jacobs. 2001. Bacteriologic and clinical efficacy of high dose amoxicillin/clavulanate in children with acute otitis media. Pediatr. Infect. Dis. J. 20:829-837.
21. Draper, S. J., and J. L. Heeney. 2010. Viruses as vaccine vectors for infectious diseases and cancer. Nat. Rev. Microbiol. 8:62-73.
22. Dudareva, M., L. Andrews, S. C. Gilbert, P. Bejon, K. Marsh, J. Mwacharo, O. Kai, A. Nicosia, and A. V. Hill. 2009. Prevalence of serum neutralizing antibodies against chimpanzee adenovirus 63 and human adenovirus 5 in Kenyan children, in the context of vaccine vector efficacy. Vaccine 27:3501-3504.
23. El-Adhami, W., J. M. Kyd, D. A. Bastin, and A. W. Cripps. 1999. Characterization of the gene encoding a 26-kilodalton protein (OMP26) from nontypeable Haemophilus influenzae and immune responses to the recombinant protein. Infect. Immun. 67:1935-1942.
24. Foxwell, A. R., J. M. Kyd, and A. W. Cripps. 2003. Mucosal immunization against respiratory bacterial pathogens. Expert Rev. Vaccines 2:551-560.
25. Gao, W., A. C. Soloff, X. Lu, A. Montecalvo, D. C. Nguyen, Y. Matsuoka, P. D. Robbins, D. E. Swayne, R. O. Donis, J. M. Katz, S. M. Barratt-Boyes, and A. Gambotto. 2006. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol. 80:1959-1964.
26. Giebink, G. S., L. O. Bakaletz, S. J. Barenkamp, B. Green, X. X. Gu, T. Heikkinen, M. Hotomi, P. Karma, Y. Kurono, J. M. Kyd, T. F. Murphy, P. L. Ogra, J. A. Patel, and S. I. Pelton. 2005. Report of the vaccination panel: eighth international otitis media research conference. Ann. Otol. Rhinol. Laryngol. 114:S86-S103.
27. He, Z., A. P. Wlazlo, D. W. Kowalczyk, J. Cheng, Z. Q. Xiang, W. Giles-Davis, and H. C. Ertl. 2000. Viral recombinant vaccines to the E6 and E7 antigens of HPV-16. Virology 270:146-161.
28. Henderson, I. R., F. Navarro-Garcia, M. Desvaux, R. C. Fernandez, and D. Ala'Aldeen. 2004. Type V protein secretion pathway: the autotransporter story. Microbiol. Mol. Biol. Rev. 68:692-744.
29. Hirano, T., Y. Hou, X. Jiao, and X. X. Gu. 2003. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx. FEMS Immunol. Med. Microbiol. 35:1-10.
30. Hoelscher, M. A., S. Garg, D. S. Bangari, J. A. Belser, X. Lu, I. Stephenson, R. A. Bright, J. M. Katz, S. K. Mittal, and S. Sambhara. 2006. Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice. Lancet 367:475-481.
31. Hoft, D. F., A. Blazevic, G. Abate, W. A. Hanekom, G. Kaplan, J. H. Soler, F. Weichold, L. Geiter, J. C. Sadoff, and M. A. Horwitz. 2008. A new recombinant bacille Calmette-Guerin vaccine safely induces significantly enhanced tuberculosis-specific immunity in human volunteers. J. Infect. Dis. 198:1491-1501.
32. Hotomi, M., N. Yamanaka, J. Shimada, M. Suzumoto, Y. Ikeda, A. Sakai, J. Arai, and B. Green. 2002. Intranasal immunization with recombinant outer membrane protein P6 induces specific immune responses against nontypeable Haemophilus influenzae. Int. J. Pediatr. Otorhinolaryngol. 65:109-116.
33. Hou, Y., W. G. Hu, T. Hirano, and X. X. Gu. 2002. A new intra-NALT route elicits mucosal and systemic immunity against Moraxella catarrhalis in a mouse challenge model. Vaccine 20:2375-2381.
34. Jurcisek, J. A., J. E. Durbin, D. F. Kusewitt, and L. O. Bakaletz. 2003. Anatomy of the nasal cavity in the chinchilla. Cells Tissues Organs 174:136-152.
35. Kawauchi, H., R. Ishimitsu, A. Murata, and A. Takahashi. 2003. Roles of toll-like receptors in IL-15 production by upper respiratory epithelial cells, abstr. P68, p. 318. Abstr. 8th Int. Symp. Recent Adv. Otitis Media.
36. Kurono, Y., and G. Mogi. 1996. Mucosal immunity of the middle ear, p. 451-458. In H. Kiyono, P. L. Ogra, and J. R. McGhee (ed.), Mucosal vaccines. Academic Press, Inc., San Diego, CA.
37. Leibovitz, E., M. R. Jacobs, and R. Dagan. 2004. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr. Infect. Dis. J. 23:1142-1152.
38. Lim, D. J., Y. M. Chun, H. Y. Lee, S. K. Moon, K. H. Chang, J. D. Li, and A. Andalibi. 2000. Cell biology of tubotympanum in relation to pathogenesis of otitis media - a review. Vaccine 19(Suppl. 1):S17-S25.
39. Limbach, K. J., and T. L. Richie. 2009. Viral vectors in malaria vaccine development. Parasite Immunol. 31:501-519.
40. Magalhaes, I., D. R. Sizemore, R. K. Ahmed, S. Mueller, L. Wehlin, C. Scanga, F. Weichold, G. Schirru, M. G. Pau, J. Goudsmit, S. Kuhlmann- Berenzon, M. Spangberg, J. Andersson, H. Gaines, R. Thorstensson, Y. A. Skeiky, J. Sadoff, and M. Maeurer. 2008. rBCG induces strong antigen-specific T cell responses in rhesus macaques in a prime-boost setting with an adenovirus 35 tuberculosis vaccine vector. PLoS One 3:e3790.
41. McGhee, J. R. 1999. Mucosal vaccines: an overview, p. 741-757. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee (ed.), Mucosal immunology, 2nd ed. Academic Press, Inc., San Diego, CA.
42. Molinier-Frenkel, V., A. Prevost-Blondel, S. S. Hong, R. Lengagne, S. Boudaly, M. K. Magnusson, P. Boulanger, and J. G. Guillet. 2003. The maturation of murine dendritic cells induced by human adenovirus is mediated by the fiber knob domain. J. Biol. Chem. 278:37175-37182.
43. Murphy, T. F., and L. C. Bartos. 1988. Human bactericidal antibody response to outer membrane protein P2 of nontypeable Haemophilus influenzae. Infect. Immun. 56:2673-2679.
44. Murphy, T. F., L. C. Bartos, P. A. Rice, M. B. Nelson, K. C. Dudas, and M. A. Apicella. 1986. Identification of a 16,600-dalton outer membrane protein on nontypeable Haemophilus influenzae as a target for human serum bactericidal antibody. J. Clin. Invest. 78:1020-1027.
45. Nakamura, A., T. F. DeMaria, D. J. Lim, and C. A. van Blitterswijk. 1991. Primary culture of chinchilla middle ear epithelium. Ann. Otol. Rhinol. Laryngol. 100:774-782.
46. Ng, P., R. J. Parks, D. T. Cummings, C. M. Evelegh, and F. L. Graham. 2000. An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum. Gene Ther. 11:693-699.
47. Novotny, L. A., L. L. Keller, J. A. Jurcisek, and L. O. Bakaletz. 2003. Intranasal immunization with a nontypeable Haemophilus influenzae adhesion- derived immunogen elicits a protective immune response in a chinchilla model of otitis media, abstr. A39, p. 172. Abstr. 8th Int. Symp. Recent Adv. Otitis Media.
48. Novotny, L. A., S. Partida-Sanchez, R. S. Munson, Jr., and L. O. Bakaletz. 2008. Differential uptake and processing of a Haemophilus influenzae P5- derived immunogen by chinchilla dendritic cells. Infect. Immun. 76:967-977.
49. Ogra, P. L., H. Faden, and R. C. Welliver. 2001. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14:430-445.
50. Paradise, J. L., T. F. Campbell, C. A. Dollaghan, H. M. Feldman, B. S. Bernard, D. K. Colborn, H. E. Rockette, J. E. Janosky, D. L. Pitcairn, M. Kurs-Lasky, D. L. Sabo, and C. G. Smith. 2005. Developmental outcomes after early or delayed insertion of tympanostomy tubes. N. Engl. J. Med. 353:576-586.
51. Paradise, J. L., H. E. Rockette, D. K. Colborn, B. S. Bernard, C. G. Smith, M. Kurs-Lasky, and J. E. Janosky. 1997. Otitis media in 2253 Pittsburgharea infants: prevalence and risk factors during the first two years of life. Pediatrics 99:318-333.
52. Philpott, N. J., M. Nociari, K. B. Elkon, and E. Falck-Pedersen. 2004. Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway. Proc. Natl. Acad. Sci. U. S. A. 101:6200-6205.
53. Piglansky, L., E. Leibovitz, S. Raiz, D. Greenberg, J. Press, A. Leiberman, and R. Dagan. 2003. Bacteriologic and clinical efficacy of high dose amoxicillin for therapy of acute otitis media in children. Pediatr. Infect. Dis. J. 22:405-413.
54. Rodrigues, E. G., F. Zavala, D. Eichinger, J. M. Wilson, and M. Tsuji. 1997. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 158:1268-1274.
55. Rosenthal, K. S., and D. H. Zimmerman. 2006. Vaccines: all things considered. Clin. Vaccine Immunol. 13:821-829.
56. Sminia, T., and G. Kraal. 1999. Nasal-associated lymphoid tissue, p. 357-364. In P. L. Ogra, J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, and J. R. McGhee (ed.), Mucosal immunology, 2nd ed. Academic Press, Inc., San Diego, CA.
57. St. Geme, J. W., III, S. Falkow, and S. J. Barenkamp. 1993. High-molecular-weight proteins of nontypable Haemophilus influenzae mediate attachment to human epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 90:2875-2879.
58. St. Geme, J. W., III, V. V. Kumar, D. Cutter, and S. J. Barenkamp. 1998. Prevalence and distribution of the hmw and hia genes and the HMW and Hia adhesins among genetically diverse strains of nontypeable Haemophilus influenzae. Infect. Immun. 66:364-368.
59. Suenaga, S., S. Kodama, S. Ueyama, M. Suzuki, and G. Mogi. 2001. Mucosal immunity of the middle ear: analysis at the single cell level. Laryngoscope 111:290-296. (Pubitemid 32142840)
60. Tatsis, N., and H. C. Ertl. 2004. Adenoviruses as vaccine vectors. Mol. Ther. 10:616-629.
61. Van Kampen, K. R., Z. Shi, P. Gao, J. Zhang, K. W. Foster, D. T. Chen, D. Marks, C. A. Elmets, and D. C. Tang. 2005. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine 23:1029-1036.
62. Velge-Roussel, F., P. Marcelo, A. C. Lepage, D. Buzoni-Gatel, and D. T. Bout. 2000. Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartments. Infect. Immun. 68:969-972.
63. Webb, D. C., and A. W. Cripps. 1999. Immunization with recombinant transferrin binding protein B enhances clearance of nontypeable Haemophilus influenzae from the rat lung. Infect. Immun. 67:2138-2144.
64. Winter, L. E., and S. J. Barenkamp. 2009. Antibodies specific for the Hia adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Clin. Vaccine Immunol. 16:1040-1046.
65. Winter, L. E., and S. J. Barenkamp. 2006. Antibodies specific for the high molecular weight adhesion proteins of nontypable Haemophilus influenzae are opsonophagocytic for both homologous and heterologous strains. Clin. Vaccine Immunol. 13:1333-1342.
66. Winter, L. E., and S. J. Barenkamp. 2003. Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activity. Infect. Immun. 71:6884-6891.
67. Woodcock, D. M., P. J. Crowther, J. Doherty, S. Jefferson, E. DeCruz, M. Noyer-Weidner, S. S. Smith, M. Z. Michael, and M. W. Graham. 1989. Quantitative evaluation of Escherichia coli host strains for tolerance to cytosine methylation in plasmid and phage recombinants. Nucleic Acids Res. 17:3469-3478.
68. Xiang, Z. Q., Y. Yang, J. M. Wilson, and H. C. Ertl. 1996. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier. Virology 219:220-227.
69. Yeo, H. J., S. E. Cotter, S. Laarmann, T. Juehne, J. W. St. Geme, and G. Waksman. 2004. Structural basis for host recognition by the Haemophilus influenzae Hia autotransporter. EMBO J. 23:1245-1256.